Literature DB >> 3007333

Autocrine models of B-lymphocyte growth. II. Interleukin-1 supports the proliferation of transformed lymphoblasts but not the stimulation of resting B cells triggered through their receptors for antigen.

J Gordon, G Guy, L Walker.   

Abstract

Purified, monocyte-derived interleukin-1 (IL-1) was found to provide growth support for Epstein-Barr virus (EBV) transformed B-lymphocytes seeded at densities below which their own autostimulatory factors were limiting. By contrast, highly purified resting B cells triggered via their receptors for antigen failed to respond to identical preparations of IL-1 by DNA synthesis. That successful priming of the B cells had occurred was evidenced by a transient rise in RNA synthesis and the ability of the cells to respond to T-cell supernatants by DNA synthesis. The findings indicate that while IL-1 might perform an autostimulatory function in B lymphocyte proliferation it is not by itself sufficient to provide growth support for resting B cells activated through their receptors for antigen. The implications of these observations for autocrine models of B-cell growth are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007333      PMCID: PMC1453825     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.

Authors:  A Muraguchi; J H Kehrl; J L Butler; A S Fauci
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

3.  Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

4.  Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.

Authors:  K Yoshizaki; T Nakagawa; K Fukunaga; T Kaieda; S Maruyama; S Kishimoto; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

Review 5.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

6.  Immortalized B lymphocytes produce B-cell growth factor.

Authors:  J Gordon; S C Ley; M D Melamed; L S English; N C Hughes-Jones
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

7.  The effects of interleukin 1 on human B cell activation and proliferation.

Authors:  R J Falkoff; A Muraguchi; J X Hong; J L Butler; C A Dinarello; A S Fauci
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.

Authors:  J Gordon; S C Ley; M D Melamed; P Aman; N C Hughes-Jones
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

9.  Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation.

Authors:  M Howard; S B Mizel; L Lachman; J Ansel; B Johnson; W E Paul
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

10.  Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.

Authors:  G Scala; Y D Kuang; R E Hall; A V Muchmore; J J Oppenheim
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  7 in total

1.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

Review 3.  Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.

Authors:  J Gordon; G Guy; L Walker; P Nathan; R Exley; M Clemens
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; H Li; E Johannsen; D Davidson; R Longnecker; E Kieff
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.

Authors:  Y L Lau; J G Shields; R J Levinsky; R E Callard
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).

Authors:  R E Callard; Y L Lau; J G Shields; S H Smith; J Cairns; L Flores-Romo; J Gordon
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

7.  Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs.

Authors:  T Matthes; C Werner-Favre; H Tang; X Zhang; V Kindler; R H Zubler
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.